Found: 57
Select item for more details and to access through your institution.
Does balanced haemostasis equate to normal coagulation in patients with acute liver failure?
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Clinical utility of viscoelastic tests of coagulation in patients with liver disease.
- Published in:
- Liver International, 2013, v. 33, n. 7, p. 961, doi. 10.1111/liv.12158
- By:
- Publication type:
- Article
Hemostasis in patients with acute kidney injury secondary to acute liver failure.
- Published in:
- Kidney International, 2013, v. 84, n. 1, p. 158, doi. 10.1038/ki.2013.92
- By:
- Publication type:
- Article
Thrombin generation assays for optimizing low molecular weight heparin dosing in pregnant women at risk of thrombosis - response to Ismail et al.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 4, p. 643, doi. 10.1111/bjh.13523
- By:
- Publication type:
- Article
Thrombin generation assay identifies individual variability in responses to low molecular weight heparin in pregnancy: implications for anticoagulant monitoring.
- Published in:
- British Journal of Haematology, 2015, v. 168, n. 5, p. 719, doi. 10.1111/bjh.13193
- By:
- Publication type:
- Article
Guideline for the diagnosis and management of the rare coagulation disorders.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 3, p. 304, doi. 10.1111/bjh.13058
- By:
- Publication type:
- Article
Exercise-based telerehabilitation for the management of chronic pain in people with severe haemophilia: a mixed-methods feasibility study.
- Published in:
- Pilot & Feasibility Studies, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40814-024-01550-z
- By:
- Publication type:
- Article
Correction to: Inhibition of Tissue Factor Pathway Inhibitor (TFPI) as a Treatment for Haemophilia: Rationale with Focus on Concizumab.
- Published in:
- Drugs, 2018, v. 78, n. 9, p. 891, doi. 10.1007/s40265-018-0933-3
- By:
- Publication type:
- Article
Inhibition of Tissue Factor Pathway Inhibitor (TFPI) as a Treatment for Haemophilia: Rationale with Focus on Concizumab.
- Published in:
- Drugs, 2018, v. 78, n. 9, p. 881, doi. 10.1007/s40265-018-0922-6
- By:
- Publication type:
- Article
Nebulized Recombinant Tissue Plasminogen Activator (rt-PA) for Acute COVID-19-Induced Respiratory Failure: An Exploratory Proof-of-Concept Trial.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 18, p. 5848, doi. 10.3390/jcm12185848
- By:
- Publication type:
- Article
A new population pharmacokinetic model for recombinant factor IX‐Fc fusion concentrate including young children with haemophilia B.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 1, p. 220, doi. 10.1111/bcp.15881
- By:
- Publication type:
- Article
Validation of a perioperative population factor VIII pharmacokinetic model with a large cohort of pediatric hemophilia a patients.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 11, p. 4408, doi. 10.1111/bcp.14864
- By:
- Publication type:
- Article
Using theory of change to co-create a programme theory for a telerehabilitation intervention for pain management in people with haemophilia.
- Published in:
- Orphanet Journal of Rare Diseases, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13023-023-02988-9
- By:
- Publication type:
- Article
The effect of SARS‐Co‐V2 infection on prothrombotic and anticoagulant factors in dialysis patients.
- Published in:
- Artificial Organs, 2022, v. 46, n. 7, p. 1328, doi. 10.1111/aor.14206
- By:
- Publication type:
- Article
Targeting an elevated FVIII level using personalized rurioctocog alfa pegol prophylaxis in specific patient populations with hemophilia A: post hoc subanalysis of the randomized, phase 3 PROPEL study.
- Published in:
- Therapeutic Advances in Hematology, 2023, v. 14, p. 1, doi. 10.1177/20406207231178596
- By:
- Publication type:
- Article
A 10-fold and greater increase in D-dimer at admission in COVID-19 patients is highly predictive of pulmonary embolism in a retrospective cohort study.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211048364
- By:
- Publication type:
- Article
Expert opinion on the UK standard of care for haemophilia patients with inhibitors: a modified Delphi consensus study.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211007058
- By:
- Publication type:
- Article
Review of recombinant anti-haemophilic porcine sequence factor VIII in adults with acquired haemophilia A.
- Published in:
- Therapeutic Advances in Hematology, 2017, v. 8, n. 9, p. 263, doi. 10.1177/2040620717720861
- By:
- Publication type:
- Article
History of non-fatal cardiovascular disease in a cohort of Dutch and British patients with haemophilia.
- Published in:
- European Journal of Haematology, 2012, v. 89, n. 4, p. 336, doi. 10.1111/j.1600-0609.2012.01835.x
- By:
- Publication type:
- Article
Retinoid-induced apoptosis in B-cell chronic lymphocytic leukaemia cells is mediated through caspase-3 activation and is independent of p53, the retinoic acid receptor, and differentiation.
- Published in:
- European Journal of Haematology, 2002, v. 69, n. 4, p. 227, doi. 10.1034/j.1600-0609.2002.02799.x
- By:
- Publication type:
- Article
Thromboelastography in the Management of Coagulopathy Associated With Ebola Virus Disease.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Oral treatment for mucopolysaccharidosis VI: Outcomes of the first phase IIa study with odiparcil.
- Published in:
- Journal of Inherited Metabolic Disease, 2022, v. 45, n. 2, p. 340, doi. 10.1002/jimd.12467
- By:
- Publication type:
- Article
Anti-tissue factor pathway inhibitor (TFPI) therapy: a novel approach to the treatment of haemophilia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Asymptomatic Joint Bleeding and Joint Health in Hemophilia: A Review of Variables, Methods, and Biomarkers.
- Published in:
- Journal of Blood Medicine, 2021, v. 12, p. 209, doi. 10.2147/JBM.S304597
- By:
- Publication type:
- Article
Therapeutic and routine prophylactic properties of rFactor VIII Fc (efraloctocog alfa, Eloctate®) in hemophilia A.
- Published in:
- Journal of Blood Medicine, 2016, v. 7, p. 187, doi. 10.2147/JBM.S80814
- By:
- Publication type:
- Article
Moving towards Normalization of haemostasis and health equity: Evolving treatment goals for haemophilia A.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1109, doi. 10.1111/hae.15031
- By:
- Publication type:
- Article
Administration of gene therapy for haemophilia – The hub and spoke model and its regional differences and challenges.
- Published in:
- Haemophilia, 2024, v. 30, n. 3, p. 855, doi. 10.1111/hae.14985
- By:
- Publication type:
- Article
EAHAD haemophilia gene therapy clinical outcome database (EAHAD‐GTD).
- Published in:
- Haemophilia, 2024, v. 30, n. 3, p. 852, doi. 10.1111/hae.14981
- By:
- Publication type:
- Article
Current and emerging gene therapies for haemophilia A and B.
- Published in:
- Haemophilia, 2024, v. 30, p. 12, doi. 10.1111/hae.14984
- By:
- Publication type:
- Article
An open‐label, multi‐centre, post‐marketing study to assess the efficacy and safety of a plasma‐derived VWF/FVIII concentrate in patients with von Willebrand disease.
- Published in:
- Haemophilia, 2024, v. 30, n. 1, p. 236, doi. 10.1111/hae.14868
- By:
- Publication type:
- Article
Bone marrow oedema syndrome as a cause of chronic knee pain in a person with severe Haemophilia A.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1668, doi. 10.1111/hae.14889
- By:
- Publication type:
- Article
Cases of less‐than‐expected FVIII activity in previously treated patients during post‐marketing surveillance of N8‐GP.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1475, doi. 10.1111/hae.14864
- By:
- Publication type:
- Article
The humanistic and economic burden of problem joints for children and adults with moderate or severe haemophilia A: Analysis of the CHESS population studies.
- Published in:
- Haemophilia, 2023, v. 29, n. 3, p. 753, doi. 10.1111/hae.14766
- By:
- Publication type:
- Article
Emicizumab prophylaxis in haemophilia A with inhibitors: Three years follow‐up from the UK Haemophilia Centre Doctors' Organisation (UKHCDO).
- Published in:
- Haemophilia, 2023, v. 29, n. 3, p. 743, doi. 10.1111/hae.14762
- By:
- Publication type:
- Article
Humanistic burden of problem joints for children and adults with haemophilia.
- Published in:
- Haemophilia, 2023, v. 29, n. 2, p. 608, doi. 10.1111/hae.14731
- By:
- Publication type:
- Article
Examining patient and professional perspectives in the UK for gene therapy in haemophilia.
- Published in:
- Haemophilia, 2022, v. 28, n. 4, p. 588, doi. 10.1111/hae.14572
- By:
- Publication type:
- Article
Gene therapy: Practical aspects of implementation.
- Published in:
- Haemophilia, 2022, v. 28, p. 44, doi. 10.1111/hae.14545
- By:
- Publication type:
- Article
Gene therapy: Practical aspects of implementation.
- Published in:
- Haemophilia, 2022, v. 28, p. 44, doi. 10.1111/hae.14545
- By:
- Publication type:
- Article
Gene therapy of hemophilia: Hub centres should be haemophilia centres: A joint publication of EAHAD and EHC.
- Published in:
- Haemophilia, 2022, v. 28, n. 3, p. e86, doi. 10.1111/hae.14546
- By:
- Publication type:
- Article
Laboratory coagulation tests and recombinant porcine factor VIII: A United Kingdom Haemophilia Centre Doctors' Organisation guideline.
- Published in:
- Haemophilia, 2022, v. 28, n. 3, p. 515, doi. 10.1111/hae.14536
- By:
- Publication type:
- Article
Clinical outcomes after joint surgery in patients on turoctocog alfa pegol (N8‐GP) prophylaxis: A post hoc analysis.
- Published in:
- Haemophilia, 2022, v. 28, n. 1, p. 158, doi. 10.1111/hae.14460
- By:
- Publication type:
- Article
Post‐hoc analysis on the long‐term response to fixed‐dose prophylaxis with N8‐GP in patients with haemophilia A.
- Published in:
- Haemophilia, 2022, v. 28, n. 1, p. 27, doi. 10.1111/hae.14409
- By:
- Publication type:
- Article
Delivery of AAV‐based gene therapy through haemophilia centres—A need for re‐evaluation of infrastructure and comprehensive care: A Joint publication of EAHAD and EHC.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 967, doi. 10.1111/hae.14420
- By:
- Publication type:
- Article
Challenges of antithrombotic therapy in the management of cardiovascular disease in patients with inherited bleeding disorders: A single‐centre experience.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 425, doi. 10.1111/hae.14296
- By:
- Publication type:
- Article
Clinical utility of sample preheat treatment in a modified Nijmegen‐Bethesda assay (mNBA) for inhibitor monitoring in congenital and acquired haemophilia A: A single‐centre four‐year experience.
- Published in:
- Haemophilia, 2020, v. 26, n. 6, p. e300, doi. 10.1111/hae.14090
- By:
- Publication type:
- Article
Long‐term safety and efficacy results from the phase 3b, open‐label, multicentre Continuation study of rurioctocog alfa pegol for prophylaxis in previously treated patients with severe haemophilia A.
- Published in:
- Haemophilia, 2020, v. 26, n. 4, p. e168, doi. 10.1111/hae.14052
- By:
- Publication type:
- Article
Physiotherapy interventions for pain management in haemophilia: A systematic review.
- Published in:
- Haemophilia, 2020, v. 26, n. 4, p. 667, doi. 10.1111/hae.14030
- By:
- Publication type:
- Article
Turoctocog alfa pegol provides effective management for major and minor surgical procedures in patients across all age groups with severe haemophilia A: Full data set from the pathfinder 3 and 5 phase III trials.
- Published in:
- Haemophilia, 2020, v. 26, n. 3, p. 450, doi. 10.1111/hae.13980
- By:
- Publication type:
- Article
Laboratory measurement of factor replacement therapies in the treatment of congenital haemophilia: A United Kingdom Haemophilia Centre Doctors' Organisation guideline.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. 6, doi. 10.1111/hae.13907
- By:
- Publication type:
- Article
Laboratory coagulation tests and emicizumab treatment A United Kingdom Haemophilia Centre Doctors' Organisation guideline.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. 151, doi. 10.1111/hae.13903
- By:
- Publication type:
- Article